Was 4β-hydroxycholesterol ever going to be a useful marker of CYP3A4 activity? [PDF]
Neuhoff S, Tucker GT.
europepmc +1 more source
Modeling and simulation of the endogenous CYP3A induction marker 4β-hydroxycholesterol during enasidenib treatment. [PDF]
Li Y +5 more
europepmc +1 more source
CYP3A-fenotype, målt som 4β-hydroksykolesterol, hos pasienter før og etter nyretransplantasjon
Bakgrunn: Cytokrom P450 3A (CYP3A)-enzymer er de viktigste enzymene i metabolisme av legemidler. Det er vist stor intra- og interdividuell variasjon i CYP3A-fenotype og 4β-hydroksykolesterol (4β-OH-K) er en aktuell endogen markør for denne variasjonen ...
Olastuen, Ane
core
Kuypers and Vanhove reply to 'Was 4β-hydroxycholesterol ever going to be a useful marker of CYP3A4 activity?' by Neuhoff and Tucker. [PDF]
Kuypers DRJ, Vanhove T.
europepmc +1 more source
Gjestad et al. reply to 'Was 4β-hydroxycholesterol ever going to be a useful marker of CYP3A4 activity?' by Neuhoff and Tucker. [PDF]
Gjestad C +3 more
europepmc +1 more source
24-Hydroxycholesterol is a substrate for hepatic cholesterol 7 alpha-hydroxylase (CYP7A)
(24S)-Hydroxycholesterol is formed from cholesterol in the brain and is important for cholesterol homeostasis in this organ. Elimination of (24S)-hydroxycholesterol has been suggested to occur in the liver but little is known about the metabolism of this
Toll, Anders, +3 more
core
4β-Hydroxycholesterol level significantly correlates with steady-state serum concentration of the CYP3A4 substrate quetiapine in psychiatric patients. [PDF]
Gjestad C +3 more
europepmc +1 more source
4β-Hydroxycholesterol Level in Patients With Rheumatoid Arthritis Before vs. After Initiation of bDMARDs and Correlation With Inflammatory State. [PDF]
Wollmann BM +6 more
europepmc +1 more source
Differences in the Serum 4β-hydroxycholesterol Levels of Patients with Chronic Hepatitis C Virus (HCV) Infection: A Possible Impact on the Efficacy and Safety of Interferon (IFN)-free Treatment. [PDF]
Hirayama T +7 more
europepmc +1 more source
27-Hydroxycholesterol in bile duct tissue promotes cholangiocarcinoma progression through estrogen receptor signaling. [PDF]
Konishi N +6 more
europepmc +1 more source

